UNLABELLED: Viral respiratory tract infections in lung transplant recipients may be severe. During three consecutive winter-spring seasons, 49 symptomatic lung transplant recipients with suspected respiratory viral infection, and 26 asymptomatic patients were investigated for presence of respiratory viruses either in 56 nasopharyngeal aspirate or 72 bronchoalveolar lavage samples taken at different times after transplantation. On the whole, 1 asymptomatic (3.4%) and 28 symptomatic (57.1%) patients were positive for human metapneumovirus (hMPV, 4 patients), influenza virus A (3 patients), and B (2 patients), respiratory syncytial virus (2 patients), human coronavirus (2 patients), human parainfluenza virus (2 patients), rhinovirus (5 patients), while 4 patients were coinfected by 2 respiratory viruses, and 5 were infected sequentially by 2 or more respiratory viruses. In bronchoalveolar lavage samples, hMPV predominated by far over the other viruses, being responsible for 60% of positive specimens, whereas other viruses were present in nasopharyngeal aspirates at a comparable rate. RT-PCR (detecting 43 positive samples/128 examined) was largely superior to monoclonal antibodies (detecting 17 positive samples only). In addition, HCMV was detected in association with a respiratory virus in 4/18 HCMV-positive patients, and was found at a high concentration (>10(5) DNA copies/ml) in 3/16 (18.7%) patients with HCMV-positive bronchoalveolar lavage samples and pneumonia. Coinfections and sequential infections by HCMV and respiratory viruses were significantly more frequent in patients with acute rejection and steroid treatment. IN CONCLUSION: (i) about 50% of respiratory tract infections of lung transplant recipients were associated with one or more respiratory viruses; (ii) hMPV largely predominates in bronchoalveolar lavage of symptomatic lung transplant recipients, thus suggesting a causative role in lower respiratory tract infections; (iii) RT-PCR appears to be the method of choice for detection of respiratory viruses in lung transplant recipients, (iv) a high HCMV load in bronchoalveolar lavage is a risk factor for viral pneumonia, suggesting some measure of intervention for the control of viral infection.
UNLABELLED: Viral respiratory tract infections in lung transplant recipients may be severe. During three consecutive winter-spring seasons, 49 symptomatic lung transplant recipients with suspected respiratory viral infection, and 26 asymptomatic patients were investigated for presence of respiratory viruses either in 56 nasopharyngeal aspirate or 72 bronchoalveolar lavage samples taken at different times after transplantation. On the whole, 1 asymptomatic (3.4%) and 28 symptomatic (57.1%) patients were positive for human metapneumovirus (hMPV, 4 patients), influenza virus A (3 patients), and B (2 patients), respiratory syncytial virus (2 patients), human coronavirus (2 patients), human parainfluenza virus (2patients), rhinovirus (5 patients), while 4 patients were coinfected by 2 respiratory viruses, and 5 were infected sequentially by 2 or more respiratory viruses. In bronchoalveolar lavage samples, hMPV predominated by far over the other viruses, being responsible for 60% of positive specimens, whereas other viruses were present in nasopharyngeal aspirates at a comparable rate. RT-PCR (detecting 43 positive samples/128 examined) was largely superior to monoclonal antibodies (detecting 17 positive samples only). In addition, HCMV was detected in association with a respiratory virus in 4/18 HCMV-positive patients, and was found at a high concentration (>10(5) DNA copies/ml) in 3/16 (18.7%) patients with HCMV-positive bronchoalveolar lavage samples and pneumonia. Coinfections and sequential infections by HCMV and respiratory viruses were significantly more frequent in patients with acute rejection and steroid treatment. IN CONCLUSION: (i) about 50% of respiratory tract infections of lung transplant recipients were associated with one or more respiratory viruses; (ii) hMPV largely predominates in bronchoalveolar lavage of symptomatic lung transplant recipients, thus suggesting a causative role in lower respiratory tract infections; (iii) RT-PCR appears to be the method of choice for detection of respiratory viruses in lung transplant recipients, (iv) a high HCMV load in bronchoalveolar lavage is a risk factor for viral pneumonia, suggesting some measure of intervention for the control of viral infection.
Authors: J L Sanchez; R M Kruger; S Paranjothi; E P Trulock; J P Lynch; C Hicks; W D Shannon; G A Storch Journal: Transplantation Date: 2001-08-27 Impact factor: 4.939
Authors: R A Vilchez; K McCurry; J Dauber; A Iacono; R Keenan; A Zeevi; B Griffith; S Kusne Journal: Clin Infect Dis Date: 2001-11-08 Impact factor: 9.079
Authors: T C Bailey; R S Buller; N A Ettinger; E P Trulock; M Gaudreault-Keener; T M Langlois; J E Fornoff; J D Cooper; G A Storch Journal: J Infect Dis Date: 1995-04 Impact factor: 5.226
Authors: Regis A Vilchez; Kenneth McCurry; James Dauber; Aldo Lacono; Bartley Griffith; John Fung; Shimon Kusne Journal: Am J Transplant Date: 2002-03 Impact factor: 8.086
Authors: Giuseppe Gerna; Fausto Baldanti; Daniele Lilleri; Maurizio Parea; Maria Torsellini; Barbara Castiglioni; Patrizio Vitulo; Carlo Pellegrini; Mario Viganò; Paolo Grossi; Maria Grazia Revello Journal: Transplantation Date: 2003-04-15 Impact factor: 4.939
Authors: S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio Journal: Semin Respir Crit Care Med Date: 2011-08-19 Impact factor: 3.119
Authors: Ryan Dare; Sonali Sanghavi; Arlene Bullotta; Maria-Cristina Keightley; Kirsten St George; Robert M Wadowsky; David L Paterson; Kenneth R McCurry; Todd A Reinhart; Shahid Husain; Charles R Rinaldo Journal: J Clin Microbiol Date: 2006-10-25 Impact factor: 5.948
Authors: M Liu; G B Mallory; M G Schecter; S Worley; S Arrigain; J Robertson; O Elidemir; L A Danziger-Isakov Journal: Pediatr Transplant Date: 2010-03-04
Authors: Susanna K P Lau; Paul Lee; Alan K L Tsang; Cyril C Y Yip; Herman Tse; Rodney A Lee; Lok-Yee So; Yu-Lung Lau; Kwok-Hung Chan; Patrick C Y Woo; Kwok-Yung Yuen Journal: J Virol Date: 2011-08-17 Impact factor: 5.103
Authors: Stuart C Sweet; Hyunsook Chin; Carol Conrad; Don Hayes; Peter S Heeger; Albert Faro; Samuel Goldfarb; Ernestina Melicoff-Portillo; Thalachallour Mohanakumar; Jonah Odim; Marc Schecter; Gregory A Storch; Gary Visner; Nikki M Williams; Karen Kesler; Lara Danziger-Isakov Journal: Am J Transplant Date: 2019-07-25 Impact factor: 8.086
Authors: John V Williams; Kathryn M Edwards; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Chiaoyin K Wang; Chin-Fen Yang; David Silva; Dan Ye; Richard R Spaete; James E Crowe Journal: J Infect Dis Date: 2010-06-15 Impact factor: 5.226
Authors: John V Williams; Zhifeng Chen; Gabriella Cseke; David W Wright; Christopher J Keefer; Sharon J Tollefson; Ann Hessell; Amy Podsiad; Bryan E Shepherd; Pietro Paolo Sanna; Dennis R Burton; James E Crowe; R Anthony Williamson Journal: J Virol Date: 2007-05-23 Impact factor: 5.103